Viewing Study NCT04593251


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-02-08 @ 1:17 AM
Study NCT ID: NCT04593251
Status: COMPLETED
Last Update Posted: 2024-04-09
First Post: 2020-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Sponsor: Calypso Biotech BV
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eosinophilic Esophagitis View
None Celiac Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti IL-15 View
None CalypsoBiotech View
None Calypso Biotech View
None Celiac Disease View
None Eosinophilic Esophagitis View